- Home
- MIRA vs MTEX Comparison
MIRA vs MTEX Comparison
Compare MIRA & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- MTEX
- Stock Information
- Founded
- MIRA 2020
- MTEX 1993
- Country
- MIRA United States
- MTEX United States
- Employees
- MIRA N/A
- MTEX N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- MIRA Health Care
- MTEX Health Care
- Exchange
- MIRA Nasdaq
- MTEX Nasdaq
- Market Cap
- MIRA 19.7M
- MTEX 19.9M
- IPO Year
- MIRA 2023
- MTEX 1999
- Fundamental
- Price
- MIRA $1.33
- MTEX $11.79
- Analyst Decision
- MIRA Strong Buy
- MTEX
- Analyst Count
- MIRA 2
- MTEX 0
- Target Price
- MIRA $14.00
- MTEX N/A
- AVG Volume (30 Days)
- MIRA 3.4M
- MTEX 1.0K
- Earning Date
- MIRA 05-27-2025
- MTEX 05-13-2025
- Dividend Yield
- MIRA N/A
- MTEX N/A
- EPS Growth
- MIRA N/A
- MTEX N/A
- EPS
- MIRA N/A
- MTEX N/A
- Revenue
- MIRA N/A
- MTEX $115,036,000.00
- Revenue This Year
- MIRA N/A
- MTEX N/A
- Revenue Next Year
- MIRA N/A
- MTEX N/A
- P/E Ratio
- MIRA N/A
- MTEX N/A
- Revenue Growth
- MIRA N/A
- MTEX N/A
- 52 Week Low
- MIRA $0.51
- MTEX $6.75
- 52 Week High
- MIRA $5.01
- MTEX $16.49
- Technical
- Relative Strength Index (RSI)
- MIRA 67.19
- MTEX 65.65
- Support Level
- MIRA $1.03
- MTEX $9.70
- Resistance Level
- MIRA $1.30
- MTEX $11.97
- Average True Range (ATR)
- MIRA 0.11
- MTEX 0.34
- MACD
- MIRA 0.02
- MTEX 0.15
- Stochastic Oscillator
- MIRA 97.44
- MTEX 92.07
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.